HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Carlos Blanche Kathy E. Magliato Alfredo Trento Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blanche, C. Articles by Trento, A. Search for Related Content PubMed PubMed Citation Articles by Blanche, C. Articles by Trento, A. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2002;123:810-815
© 2002 The American Association for Thoracic Surgery

Cardiothoracic Transplantation (TX)

Heart transplantation with donors fifty years of age and older

From the Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, Calif.

Received for publication May 4, 2001. Revisions requested June 29, 2001; revisions received Aug 1, 2001. Accepted for publication Aug 31, 2001. Address for reprints: Carlos Blanche, MD, Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Suite 6215, Los Angeles, CA 90048 (E-mail: Carlos.Blanche{at}cshs.org).

Objective: Limited availability of donor organs has led to the progressive expansion of the criteria for donor selection, particularly a higher age limit of potential donors. We retrospectively reviewed the outcomes of patients who underwent heart transplantation using cardiac allografts 50 years of age and older and compared them with patients who had donor organs younger than 50 years.
Method: Between September 1989 and May 2000, 20 patients underwent orthotopic heart transplantation using donor hearts 50 years of age and older (range 50-56 years, mean 52.7 ± 1.8 years) and were compared with 267 patients who received donor organs less than 50 years of age (range 9-49.9 years, mean 27.2 ± 8.6 years). Patient and donor criteria were identical in both groups. Follow-up was 4 to 128 months with a mean of 37.4 ± 2.8 months in the older donor group and 52.6 ± 2.4 months in the younger donor group.
Results: There were no differences between these 2 cohorts of patients regarding age, sex, cardiomyopathy, preoperative cytomegalovirus status, New York Heart Association class, and transplant status at transplantation. Donor characteristics, including sex, left ventricular ejection fraction, diabetes, cytomegalovirus status, and allograft ischemic times, were also similar in the 2 groups. Donor/recipient cytomegalovirus matching showed no differences as well. Thirty-day or to discharge operative mortality was similar in the older and younger donor groups (5% ± 4.8% vs 3.5% ± 1.1%; P = .84). Actuarial survival at 1 and 5 years was also similar in both groups (89.7% ± 6.9% vs 91% ± 1.8% and 53.1% ± 14.7% vs 71.0% ± 3.1%, respectively; P = .59). No patient in the older donor group required coronary artery bypass grafting or retransplantation during the follow-up period, whereas 2 patients in the younger donor group required coronary artery bypass, and 5 patients underwent retransplantation (P .50). Two patients in the older donor group died of nonspecific allograft failure, whereas 3 patients in the younger donor group experienced similar posttransplant complication (P .50).
Conclusions: Carefully selected donor hearts 50 years of age and older can be used for heart transplantation with long-term survival and related outcomes similar to those of younger donor organs. This use of selective cardiac allografts maximizes donor organ usage and expands the donor pool effectively without an adverse impact on long-term results.

This article has been cited by other articles:

				V. W. Tsai, J. Cooper, H. Garan, A. Natale, L. M. Ptaszek, P. T. Ellinor, K. Hickey, R. Downey, P. Zei, H. Hsia, et al. The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients: Results From a Multicenter Registry Circ Heart Fail, May 1, 2009; 2(3): 197 - 201. [Abstract] [Full Text] [PDF]

				N. D. Patel, E. S. Weiss, L. U. Nwakanma, S. D. Russell, W. A. Baumgartner, A. S. Shah, and J. V. Conte Impact of Donor-to-Recipient Weight Ratio on Survival After Heart Transplantation: Analysis of the United Network for Organ Sharing Database Circulation, September 30, 2008; 118(14_suppl_1): S83 - S88. [Abstract] [Full Text] [PDF]

				K. J. Shea, N. A Sopko, K. Ludrosky, K. Hoercher, N. G. Smedira, D. O. Taylor, R. C. Starling, and G. V. Gonzalez-Stawinski The effect of a donor's history of active substance on outcomes following orthotopic heart transplantation Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 452 - 456. [Abstract] [Full Text] [PDF]